Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period.

Autor: Mandić Z; Department of ophthalmology, Clinical Department of Ophthalmology Hospital Sisters of Charity, Refferal Center for Glaucoma, Ministry of Health and Welfare of Republic of Croatia, Zagreb., Novak-Laus K, Bojić L, Popović-Suić S, Ekert M, Dosen VM, Pelcić G, Clementi D, Dobutović D, Biuk D, Iveković R, Kovacić Z, Pavan J, Susić N, Geser MZ, Krolo I, Barisić F, Jurić-Miletić A, Dogan KK, Tomić M, Kovacević S

Publikováno v: Acta clinica Croatica [Acta Clin Croat] 2010 Dec; Vol. 49 (4), pp. 411-9.